• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的三级淋巴结构:在抗肿瘤免疫中的双刃剑作用及潜在的治疗诱导策略

Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies.

作者信息

Kang Wendi, Feng Zhichao, Luo Jianwei, He Zhenhu, Liu Jun, Wu Jianzhen, Rong Pengfei

机构信息

Department of Radiology, The Third Xiangya Hospital of Central South University, Changsha, China.

Molecular Imaging Research Center, Central South University, Changsha, China.

出版信息

Front Immunol. 2021 Jul 29;12:689270. doi: 10.3389/fimmu.2021.689270. eCollection 2021.

DOI:10.3389/fimmu.2021.689270
PMID:34394083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8358404/
Abstract

The complex tumor microenvironment (TME) plays a vital role in cancer development and dramatically determines the efficacy of immunotherapy. Tertiary lymphoid structures (TLSs) within the TME are well recognized and consist of T cell-rich areas containing dendritic cells (DCs) and B cell-rich areas containing germinal centers (GCs). Accumulating research has indicated that there is a close association between tumor-associated TLSs and favorable clinical outcomes in most types of cancers, though a minority of studies have reported an association between TLSs and a poor prognosis. Overall, the double-edged sword role of TLSs in the TME and potential mechanisms need to be further investigated, which will provide novel therapeutic perspectives for antitumor immunoregulation. In this review, we focus on discussing the main functions of TLSs in the TME and recent advances in the therapeutic manipulation of TLSs through multiple strategies to enhance local antitumor immunity.

摘要

复杂的肿瘤微环境(TME)在癌症发展中起着至关重要的作用,并极大地决定了免疫治疗的疗效。TME中的三级淋巴结构(TLSs)已得到充分认识,由富含T细胞的区域(包含树突状细胞(DCs))和富含B细胞的区域(包含生发中心(GCs))组成。越来越多的研究表明,在大多数类型的癌症中,肿瘤相关的TLSs与良好的临床结果之间存在密切关联,尽管少数研究报告了TLSs与不良预后之间的关联。总体而言,TLSs在TME中的双刃剑作用及其潜在机制需要进一步研究,这将为抗肿瘤免疫调节提供新的治疗视角。在这篇综述中,我们着重讨论TLSs在TME中的主要功能以及通过多种策略对TLSs进行治疗性调控以增强局部抗肿瘤免疫力的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a59/8358404/d241c63d25bb/fimmu-12-689270-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a59/8358404/231202406322/fimmu-12-689270-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a59/8358404/3e0b6e220db9/fimmu-12-689270-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a59/8358404/d241c63d25bb/fimmu-12-689270-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a59/8358404/231202406322/fimmu-12-689270-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a59/8358404/3e0b6e220db9/fimmu-12-689270-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a59/8358404/d241c63d25bb/fimmu-12-689270-g003.jpg

相似文献

1
Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies.癌症中的三级淋巴结构:在抗肿瘤免疫中的双刃剑作用及潜在的治疗诱导策略
Front Immunol. 2021 Jul 29;12:689270. doi: 10.3389/fimmu.2021.689270. eCollection 2021.
2
Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes.三级淋巴结构作为与肿瘤浸润免疫细胞的组织、教育和功能相关的独特结构。
J Zhejiang Univ Sci B. 2022 Oct 15;23(10):812-822. doi: 10.1631/jzus.B2200174.
3
Tertiary lymphoid structures in cancer.癌症中的三级淋巴结构。
Science. 2022 Jan 7;375(6576):eabf9419. doi: 10.1126/science.abf9419.
4
Tertiary lymphoid structures in the era of cancer immunotherapy.癌症免疫治疗时代的三级淋巴结构。
Nat Rev Cancer. 2019 Jun;19(6):307-325. doi: 10.1038/s41568-019-0144-6.
5
The roles of tertiary lymphoid structures in genitourinary cancers: molecular mechanisms, therapeutic strategies, and clinical applications.三阴性淋巴结构在泌尿生殖系统癌症中的作用:分子机制、治疗策略和临床应用。
Int J Surg. 2024 Aug 1;110(8):5007-5021. doi: 10.1097/JS9.0000000000001939.
6
Tertiary lymphoid structures and their therapeutic implications in cancer.三级淋巴结构及其在癌症中的治疗意义。
Cell Oncol (Dordr). 2024 Oct;47(5):1579-1592. doi: 10.1007/s13402-024-00975-1. Epub 2024 Aug 12.
7
Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma.肿瘤内三级淋巴结构可提高头颈部鳞状细胞癌患者的生存率和免疫治疗反应。
Cancer Immunol Immunother. 2023 Jun;72(6):1505-1521. doi: 10.1007/s00262-022-03310-5. Epub 2022 Dec 8.
8
Tertiary lymphoid structures: new immunotherapy biomarker.三级淋巴结构:新的免疫治疗标志物。
Front Immunol. 2024 Jul 4;15:1394505. doi: 10.3389/fimmu.2024.1394505. eCollection 2024.
9
Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.肿瘤内三级淋巴结构与肝细胞癌早期复发风险低相关。
J Hepatol. 2019 Jan;70(1):58-65. doi: 10.1016/j.jhep.2018.09.003. Epub 2018 Sep 11.
10
Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer.胃癌原发灶周围三级淋巴结构的免疫潜能。
Int J Oncol. 2020 Jul;57(1):171-182. doi: 10.3892/ijo.2020.5042. Epub 2020 Apr 8.

引用本文的文献

1
Density and Maturity of Tertiary Lymphoid Structures Predict Clinical Outcome in Invasive Lung Adenocarcinoma.三级淋巴结构的密度和成熟度可预测浸润性肺腺癌的临床结局。
Cancer Control. 2025 Jan-Dec;32:10732748251372684. doi: 10.1177/10732748251372684. Epub 2025 Aug 31.
2
In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy.深入了解与三级淋巴结构相关的肿瘤浸润性基质细胞及其在癌症免疫治疗中的潜在功能。
Exp Hematol Oncol. 2025 Aug 10;14(1):105. doi: 10.1186/s40164-025-00695-8.
3
Interleukin Family-Based Signature Relates to Cancer-Associated Fibroblasts Spatial Distribution and Immune Therapy Response in Pancreatic Carcinoma.

本文引用的文献

1
STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment.基于 STING 激动剂的治疗促进了治疗性黑色素瘤微环境中的血管正常化和三级淋巴结构形成。
J Immunother Cancer. 2021 Feb;9(2). doi: 10.1136/jitc-2020-001906.
2
The Role of Anti-angiogenesis in the Treatment Landscape of Non-small Cell Lung Cancer - New Combinational Approaches and Strategies of Neovessel Inhibition.抗血管生成在非小细胞肺癌治疗格局中的作用——新的血管生成抑制联合方法与策略
Front Cell Dev Biol. 2021 Jan 5;8:610903. doi: 10.3389/fcell.2020.610903. eCollection 2020.
3
基于白细胞介素家族的特征与胰腺癌中癌症相关成纤维细胞的空间分布及免疫治疗反应相关。
J Inflamm Res. 2025 Jul 29;18:10129-10146. doi: 10.2147/JIR.S532651. eCollection 2025.
4
Novel association between graft rejection and post-transplant malignancy in solid organ transplantation.实体器官移植中移植排斥与移植后恶性肿瘤之间的新型关联。
World J Transplant. 2025 Jun 18;15(2):102384. doi: 10.5500/wjt.v15.i2.102384.
5
B cells and tertiary lymphoid structures in cancer therapy response.癌症治疗反应中的B细胞和三级淋巴结构
BJC Rep. 2025 May 28;3(1):40. doi: 10.1038/s44276-025-00146-1.
6
Tertiary Lymphoid Structures Are Associated with Progression-Free Survival of Peripheral Neuroblastic Tumor Patients.三级淋巴结构与外周神经母细胞瘤患者的无进展生存期相关。
Cancers (Basel). 2025 Apr 12;17(8):1303. doi: 10.3390/cancers17081303.
7
The role of immunotherapy in targeting tumor microenvironment in genitourinary cancers.免疫疗法在靶向泌尿生殖系统癌症肿瘤微环境中的作用。
Front Immunol. 2025 Apr 7;16:1506278. doi: 10.3389/fimmu.2025.1506278. eCollection 2025.
8
The impact of metabolic reprogramming on tertiary lymphoid structure formation: enhancing cancer immunotherapy.代谢重编程对三级淋巴结构形成的影响:增强癌症免疫治疗。
BMC Med. 2025 Apr 14;23(1):217. doi: 10.1186/s12916-025-04037-7.
9
Tertiary lymphoid structures in colorectal cancer - organization and immune cell interactions.结直肠癌中的三级淋巴结构——组织与免疫细胞相互作用
Am J Clin Exp Immunol. 2024 Dec 25;13(6):236-245. doi: 10.62347/GRYY2849. eCollection 2024.
10
TLR7/8/9 agonists and low-dose cisplatin synergistically promotes tertiary lymphatic structure formation and antitumor immunity.Toll样受体7/8/9激动剂与低剂量顺铂协同促进三级淋巴结构形成和抗肿瘤免疫。
NPJ Vaccines. 2025 Jan 19;10(1):13. doi: 10.1038/s41541-024-01055-z.
Tumor-infiltrating lymphocytes in the immunotherapy era.
免疫治疗时代的肿瘤浸润淋巴细胞。
Cell Mol Immunol. 2021 Apr;18(4):842-859. doi: 10.1038/s41423-020-00565-9. Epub 2020 Nov 2.
4
Insights into Tumor-Associated Tertiary Lymphoid Structures: Novel Targets for Antitumor Immunity and Cancer Immunotherapy.肿瘤相关三级淋巴结构的研究进展:抗肿瘤免疫和癌症免疫治疗的新靶点。
Cancer Immunol Res. 2020 Nov;8(11):1338-1345. doi: 10.1158/2326-6066.CIR-20-0432.
5
Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors.切除的无功能胰腺神经内分泌肿瘤中三级淋巴结构的浸润模式和预后价值。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-001188.
6
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial.术前伊匹单抗联合纳武利尤单抗治疗局部晚期尿路上皮癌:NABUCCO 试验。
Nat Med. 2020 Dec;26(12):1839-1844. doi: 10.1038/s41591-020-1085-z. Epub 2020 Oct 12.
7
Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma.三级淋巴结构和肿瘤浸润淋巴细胞在口腔鳞状细胞癌中的预后价值。
Int J Oral Sci. 2020 Sep 15;12(1):24. doi: 10.1038/s41368-020-00092-3.
8
Cell and tissue engineering in lymph nodes for cancer immunotherapy.淋巴结中的细胞和组织工程用于癌症免疫治疗。
Adv Drug Deliv Rev. 2020;161-162:42-62. doi: 10.1016/j.addr.2020.07.023. Epub 2020 Aug 1.
9
TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy.TNFSF14:为有效的癌症免疫疗法指明道路。
Front Immunol. 2020 May 15;11:922. doi: 10.3389/fimmu.2020.00922. eCollection 2020.
10
RNA delivery by extracellular vesicles in mammalian cells and its applications.外泌体在哺乳动物细胞中传递 RNA 及其应用。
Nat Rev Mol Cell Biol. 2020 Oct;21(10):585-606. doi: 10.1038/s41580-020-0251-y. Epub 2020 May 26.